Principles and Techniques for Improving Preclinical Translation in Alzheimer's Disease

About

We invite you to join us for an immersion workshop focusing on the improvement of preclinical translation in Alzheimer’s Disease research. This workshop will leverage the expertise and facilities of the Indiana University (IU)/JAX Model Organism Development for Evaluation of Late Onset Alzheimer’s Disease (MODEL-AD) Precision Medicine consortium.  We aim to address training gaps in preclinical drug screening by providing you with the skills and knowledge required for rigorous design, execution, analysis, and reporting of pharmacokinetic, pharmacodynamics, and preclinical efficacy experiments. Additionally, we will focus on the selection and appropriate use of mouse models in translational research.

Through this workshop, you will experience a significant amount of hands-on, practical laboratory training in in vivo drug screening.  We also strive to support you in your research project and career advancement through networking with experts and peers to promote collaborative research.

Research reported in this publication was supported by the National Institute on Aging of the National Institutes of Health under Award Number R13AG060708. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.